Haemonetics Corporation (HAE)
NYSE: HAE · IEX Real-Time Price · USD
86.22
+1.15 (1.35%)
Apr 24, 2024, 4:00 PM EDT - Market closed
Haemonetics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Haemonetics stock have an average target of 102.5, with a low estimate of 94 and a high estimate of 115. The average target predicts an increase of 18.88% from the current stock price of 86.22.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Haemonetics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
Buy | 3 | 3 | 3 | 2 | 2 | 2 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 6 | 6 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barrington Research | Barrington Research | Buy Maintains $105 | Buy | Maintains | $105 | +21.78% | Apr 12, 2024 |
Barrington Research | Barrington Research | Buy Reiterates $105 | Buy | Reiterates | $105 | +21.78% | Feb 13, 2024 |
Barrington Research | Barrington Research | Buy Maintains $114 → $105 | Buy | Maintains | $114 → $105 | +21.78% | Nov 3, 2023 |
Citigroup | Citigroup | Hold Maintains $90 → $94 | Hold | Maintains | $90 → $94 | +9.02% | Oct 2, 2023 |
Barrington Research | Barrington Research | Buy Maintains $111 → $114 | Buy | Maintains | $111 → $114 | +32.22% | Aug 9, 2023 |
Financial Forecast
Revenue This Year
1.31B
from 1.17B
Increased by 11.92%
Revenue Next Year
1.38B
from 1.31B
Increased by 5.81%
EPS This Year
4.00
from 2.24
Increased by 78.51%
EPS Next Year
4.45
from 4.00
Increased by 11.32%
Revenue Forecast
Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|
High | 1.4B | 1.5B | 1.6B | 1.7B | 1.9B |
Avg | 1.3B | 1.4B | 1.5B | 1.6B | 1.8B |
Low | 1.3B | 1.3B | 1.4B | 1.6B | 1.7B |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|
High | 16.6% | 13.8% | 15.2% | 15.9% | 14.4% |
Avg | 11.9% | 5.8% | 5.3% | 11.5% | 10.0% |
Low | 8.4% | -1.3% | -2.1% | 8.2% | 6.8% |
EPS Forecast
EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|
High | 4.19 | 4.83 | 5.30 | 6.48 | 7.44 |
Avg | 4.00 | 4.45 | 4.94 | 6.23 | 7.16 |
Low | 3.86 | 4.17 | 4.70 | 6.05 | 6.95 |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|
High | 87.0% | 20.8% | 19.1% | 31.3% | 19.5% |
Avg | 78.5% | 11.3% | 10.9% | 26.3% | 14.9% |
Low | 72.4% | 4.2% | 5.6% | 22.5% | 11.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.